Aman Expands on Two Fronts as Wellness Capital Keeps Flowing

Aman is expanding its wellness footprint in two directions at once. Amangati, the brand's first at-sea property, has completed its float-out, and bookings are now open for spring 2027 Mediterranean sailings plus a newly announced winter 2027-28 Caribbean season — a concrete, sellable spa-cruise product advisors can put in front of clients well before the ship's actual launch. Separately, Shinsegae-OKO has committed to a $500M joint venture with Aman and sister brand Janu to build out destination-spa properties across Asia Pacific, pointing to a substantial pipeline of new inventory in the region over the next several years. Neither development is a finished product yet, but both are actionable now: one as a bookable 2027 itinerary, the other as an early signal to start positioning high-net-worth clients ahead of openings and inevitable waitlists once locations are confirmed.

• Amangati: bookings open for spring 2027 Mediterranean sailings and winter 2027-28 Caribbean season
• Shinsegae-OKO's $500M JV with Aman/Janu targets new APAC destination-spa development

Nova Capital has committed $100M to a longevity venture in the UAE structured as an integrated ecosystem rather than a single clinic — spanning diagnostics, treatment, and lifestyle programming under one investment thesis. That framing matters for advisors: it suggests Abu Dhabi and Dubai are angling to become a full longevity destination, not just a stopover for one procedure, positioning the region to compete with established names like Clinique La Prairie and SHA Wellness. Nothing is bookable yet, and the venture's specific properties and partners haven't been named, but the scale of capital is a clear early marker. Advisors with longevity-focused clients should flag this as a market to watch for program announcements and consortium partnerships over the coming year, rather than something to sell today.

ISPA's full 2026 US Spa Industry Study confirms another year of growth, with annual industry revenue up $1B. For advisors, that's usable ammunition in pricing conversations: it backs continued demand for domestic destination-spa and resort-spa packages at a moment when clients may be questioning value against rising rates. The study is a benchmark rather than a breaking development, but it's the clearest hard data point available this cycle to support that spa and wellness travel keeps growing rather than plateauing, useful when framing recommendations to clients weighing a spa stay against other travel spend.